Home » Topics » BioWorld Science

BioWorld Science
RSS

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

Squalene synthase inhibitors patented by Pfizer

Jan. 26, 1998

SS Pharm. describes new triazoles with oral activity

Jan. 26, 1998

Matritech receives SBIR grant for cancer test development

Jan. 26, 1998

Laminin-related polypeptides from the University of Minnesota

Jan. 26, 1998

Quilimmune-P enters phase II

Jan. 23, 1998

Antegren meets development criteria in phase II trial

Jan. 23, 1998

Boston Life Sciences to seek U.S. approval for Therafectin

Jan. 23, 1998

Alkermes, Johnson & Johnson to codevelop novel formulation of erythropoietin

Jan. 23, 1998

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...